Drugs for Treating Mental Disorders: Technologies and Global Markets

Jan 2011| PHM074A| BCC Publishing

Report Highlights

The global mental health pharmaceutical market can be estimated at $80 billion in 2010. This market is expected to increase at a 1.9% compound annual growth rate (CAGR) over the forecast period to reach a value of $88 billion in 2015.

SCOPE OF REPORT

The subject of the mental health pharmaceutical industry is complex and requires a proper and timely evaluation of current products and most importantly new drug development trends. The geographic scope of this study covers U.S. and global companies. The report identifies the major drug categories in the mental health pharmaceutical industry such as antidepressants, anxiolytics, and other psychiatric drug categories. This study describes current products in each category, identifies current market participants and, notes the new drug development that will affect new opportunities in this area of medicine.

ANALYST CREDENTIALS

Dr. Marianna Tcherpakov has more than 7 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, and industrial assay development. She holds her PhD in Molecular Neurobiology and has contributed to a number of scientific publications related to research into central nervous system diseases.

Frequently Asked Questions (FAQs)

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Drugs for Treating Mental Disorders: Technologies and Global Markets159Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY3Free
Chapter- 3: INTRODUCTION18Free
Chapter- 4: DEPRESSION AND THE ANTIDEPRESSANTS DRUG MARKET15Free
Chapter- 5: ANTIPSYCHOTICS MEDICATION MARKET5Free
Chapter- 6: ANXIETY DISORDERS AND THE DRUG MARKET FOR ANXIOLYTICS9Free
Chapter- 7: SCHIZOPHRENIA11Free
Chapter- 8: CHILDHOOD AND ADOLESCENT MENTAL DISORDERS11Free
Chapter- 9: BIPOLAR DISORDER8Free
Chapter- 10: EATING DISORDERS 6Free
Chapter- 11: COGNITIVE DISORDERS AS MENTAL HEALTH ILLNESSES17Free
Chapter- 12: SUBSTANCE AND ALCOHOL ADDICTIONS AS MENTAL HEALTH DISORDERS6Free
Chapter- 13: PERSONALITY DISORDERS3Free
Chapter- 14: SLEEP DISORDERS AS MENTAL HEALTH CONDITIONS5Free
Chapter- 15: ADDITIONAL MARKETS FOR DRUGS TO TREAT MENTAL DISORDERS 2Free
Chapter- 16: MENTAL HEALTH PHARMACEUTICAL MARKETS BY GEOGRAPHIC REGION5Free
Chapter- 17: EXAMPLES OF ECONOMIC COSTS IN TREATING MENTAL DISORDERS2Free
Chapter- 18: LEGAL ISSUES AND LAWSUITS IN THE PHARMACEUTICAL INDUSTRY FOR MENTAL DISORDERS3Free
Chapter- 19: MARKET SUMMARY24Free
Chapter- 20: APPENDIX ONE ACRONYMS1Free
Chapter- 21: APPENDIX TWO: LIST OF ADDITIONAL SOURCES2Free
Drugs for Treating Mental Disorders: Technologies and Global Markets

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
RELATED REPORTS